| 2022-05-10 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,375 0.0021% | $21.51 | $29,576 | -1.56% | |
| 2022-02-23 | Sale | Genasys Inc. GNSS | director | 13,716 0.0377% | $3.14 | $43,068 | -0.32% | |
| 2022-01-31 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,238 0.002% | $27.40 | $33,921 | -11.82% | |
| 2022-01-24 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 2,063 0.0031% | $24.98 | $51,534 | -5.13% | |
| 2022-01-11 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 7,500 0.0118% | $27.40 | $205,500 | -10.81% | |
| 2021-08-17 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,407 0.002% | $17.12 | $24,085 | +30.66% | |
| 2021-05-12 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 2,000 0.0033% | $19.46 | $38,920 | +30.12% | |
| 2021-05-11 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 2,000 0.0032% | $19.14 | $38,280 | +27.23% | |
| 2021-03-10 | Sale | Genasys Inc. GNSS | director | 5,456 0.0163% | $7.42 | $40,465 | -28.13% | |
| 2021-02-08 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 2,250 0.0041% | $31.58 | $71,055 | -19.42% | |
| 2021-02-05 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 2,250 0.004% | $31.41 | $70,673 | -21.33% | |
| 2021-02-03 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 3,625 0.0061% | $28.91 | $104,799 | -17.7% | |
| 2021-02-02 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 3,625 0.0069% | $30.75 | $111,469 | -13.09% | |
| 2020-11-25 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 3,750 0.0079% | $22.72 | $85,200 | +8.77% | |
| 2020-11-24 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 3,750 0.0081% | $23.86 | $89,475 | +6.21% | |
| 2020-11-16 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 7,500 0.0157% | $23.98 | $179,813 | +2.51% | |
| 2020-11-13 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 7,500 0.0157% | $23.61 | $177,071 | +4.14% | |
| 2020-09-23 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,500 0.0031% | $18.48 | $27,720 | +31.7% | |
| 2020-09-22 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,500 0.0029% | $18.59 | $27,885 | +23.98% | |
| 2020-05-12 | Sale | Travere Therapeutics, Inc. TVTX | Chief Financial Officer | 1,777 0.0041% | $17.11 | $30,401 | +30.78% |